NOTCH1 and neoplasm: As if to confirm these assumptions, other studies have shown that increased NOTCH1 signalling and enhanced stemness can render tumour tissues less sensitive to standard chemotherapeutic agents, such as cisplatin, docetaxel, and 5-FU [111].